Immunomics firm reels in $14m to advance drug discovery
Immunomics firm reels in $14m to advance drug discovery ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology. ImmunoScape, a biotech firm whose offerings include an immunomics-based technology platform designed to provide novel insights into the human immune system, has sealed up a $14m USD fundraising round. The infusion of investor cash brings the company’s total funding over the course of the past year to $25m USD. According to the company, the money will be us...
Source: outsourcing-pharma.com